Obesity Paradox in Patients With Non–Small Cell Lung Cancer Treated With Immunotherapy—Reply

Research output: Contribution to journalLetterpeer-review

Abstract

We thank Sanchez and Furberg for their thoughtful comments in response to our recent article in JAMA Oncology on the association between body mass index (BMI) and overall survival with immune checkpoint inhibitor therapy for patients with advanced non–small cell lung cancer.1 We agree that the association of body size with survival outcomes in patients with advanced cancer is complex and evolving.
Original languageEnglish
Pages (from-to)941-942
Number of pages2
JournalJAMA Oncology
Volume6
Issue number6
Early online date23 Apr 2020
DOIs
Publication statusPublished - Jun 2020

Fingerprint Dive into the research topics of 'Obesity Paradox in Patients With Non–Small Cell Lung Cancer Treated With Immunotherapy—Reply'. Together they form a unique fingerprint.

Cite this